Expression of Target in Endometriotic Lesions
ConditionEndometriosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-50
SponsorBeijing Tsinghua Chang Gung Hospital
About this trial
Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pathologically confirmed endometriosis via laparoscopy and histopathological examination
Complete clinical and pathological data available
Disqualifiers
None
Trial population
Female reproductive-aged patients with histopathologically confirmed endometriosis . Patients with malignant gynecological diseases are excluded.
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Retrospective molecular expression analysis in endometriosis tissue specimens
Other interventionThis study involves no prospective interventional measures for participants.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: patients with endometriosis1 intervention
Trial outcomes
Primary outcomes
1
Expression levels of molecular in endometriotic lesions and adjacent normal tissue
Standardized pathological histology assessment method
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov